Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Lung Diseases, Interstitial × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Immunoblastic Lymphadenopathy 1 HTLV-I Infections 1 Enteropathy-Associated T-Cell Lymphoma 1 Congenital Abnormalities 1

Interventions

Prednisone 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡